Literature DB >> 19811850

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy.

Alan Menter1, Neil J Korman2, Craig A Elmets3, Steven R Feldman4, Joel M Gelfand5, Kenneth B Gordon6, Alice Gottlieb7, John Y M Koo8, Mark Lebwohl9, Henry W Lim10, Abby S Van Voorhees11, Karl R Beutner12, Reva Bhushan13.   

Abstract

Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this fifth of 6 sections of the guidelines of care for psoriasis, we discuss the use of ultraviolet (UV) light therapy for the treatment of patients with psoriasis. Treatment should be tailored to meet individual patients' needs. We will discuss in detail the efficacy and safety as well as offer recommendations for the use of phototherapy, including narrowband and broadband UVB and photochemotherapy using psoralen plus UVA, alone and in combination with topical and systemic agents. We will also discuss the available data for the use of the excimer laser in the targeted treatment of psoriasis. Finally, where available, we will summarize the available data that compare the safety and efficacy of the different forms of UV light therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19811850     DOI: 10.1016/j.jaad.2009.08.026

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  65 in total

1.  American academy of dermatology, summer academy meeting.

Authors:  Takaharu Kato; Peter Sonnenreich
Journal:  P T       Date:  2011-11

Review 2.  Assessing long-term drug safety: lessons (re) learned from raptiva.

Authors:  Nicole M Seminara; Joel M Gelfand
Journal:  Semin Cutan Med Surg       Date:  2010-03

Review 3.  [Allergic diseases in pregnancy. Overview of diagnosis and therapy].

Authors:  R Treudler
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

Review 4.  Hydrogel-Based Active Substance Release Systems for Cosmetology and Dermatology Application: A Review.

Authors:  Martyna Zagórska-Dziok; Marcin Sobczak
Journal:  Pharmaceutics       Date:  2020-04-26       Impact factor: 6.321

Review 5.  Diagnosis and management of psoriasis.

Authors:  Whan B Kim; Dana Jerome; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-04       Impact factor: 3.275

Review 6.  Treatment of Eczema: Corticosteroids and Beyond.

Authors:  Melanie Chong; Luz Fonacier
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

7.  Malaysian Clinical Practice Guideline for the Management of Psoriasis Vulgaris: Summary of recommendations for management in primary healthcare setting.

Authors:  Se Choon; Lc Chan; Siew Eng Choon; Adawiyah Jamil; Chan Lee Chin; Chong Hwee Cheng; Dawn Ambrose; Hazreen Abdul Majid; Koh Chang Heng; Loh Yet Lin; Mohd Aminuddin Mohd Yusof; Sin Lian Thye; Suganthi Thevarajah; Suriati Hashim; Tang Jyhe Jong; Wong Su Ming; Yunus Shariff
Journal:  Malays Fam Physician       Date:  2014-04-30

8.  Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial.

Authors:  L Kemeny; M Amaya; P Cetkovska; N Rajatanavin; W-R Lee; A Szumski; L Marshall; E Y Mahgoub; E Aldinç
Journal:  BMC Dermatol       Date:  2015-05-21

Review 9.  [Children and adolescents with psoriasis. What therapy is recommended?].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

Review 10.  Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.

Authors:  Carolyn Jean Chua-Aguilera; Burkhard Möller; Nikhil Yawalkar
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.